Bank of America’s Quest Diagnostics DGX Stock Holding History

Bank of America’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-50,000	Closed	-$7.76M	–	8231
2024 Q3	$7.76M	Buy	+50,000	New	+$7.47M	﹤0.01%	3313
2019 Q1	–	Sell	-5,400	Closed	-$450K	–	7159
2018 Q4	$450K	Buy	+5,400	New	+$506K	﹤0.01%	5000
2014 Q3	–	Sell	-50,000	Closed	-$2.94M	–	8027
2014 Q2	$2.94M	Buy	50,000 +45,000	+900%	+$2.64M	﹤0.01%	3030
2014 Q1	$290K	Hold	5,000	–	–	﹤0.01%	5107
2013 Q4	$268K	Buy	+5,000	New	+$297K	﹤0.01%	5316
2013 Q3	–	Sell	-30,000	Closed	-$1.82M	–	7897
2013 Q2	$1.82M	Buy	+30,000	New	+$1.79M	﹤0.01%	3330

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Bank of America's DGX Position: Q1 2026 in Review

Bank of America increased its Quest Diagnostics (DGX) stake by 8% in Q1 2026, buying an estimated $25.3M and bringing the position to 1,752,902 shares worth $344M. The position accounts for 0.03% of the portfolio, ranked #518.

Bank of America first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $559M in Q4 2021. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Bank of America held 1,752,902 shares of Quest Diagnostics worth $344M as of Q1 2026.
Bank of America bought 129,964 Quest Diagnostics shares in Q1 2026, an estimated $25.3M.
Quest Diagnostics made up 0.03% of Bank of America's portfolio in Q1 2026, its #518 holding.
Bank of America first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
Bank of America's Quest Diagnostics position peaked at $559M in Q4 2021.
1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.